SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-165325
Filing Date
2021-05-18
Accepted
2021-05-18 16:08:10
Documents
12
Period of Report
2021-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d157029d8k.htm   iXBRL 8-K 26256
  Complete submission text file 0001193125-21-165325.txt   150598

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20210514.xsd EX-101.SCH 3109
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20210514_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20210514_pre.xml EX-101.PRE 11431
5 EXTRACTED XBRL INSTANCE DOCUMENT d157029d8k_htm.xml XML 3360
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 21936027
SIC: 2834 Pharmaceutical Preparations